StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultMay 14, 2026, 04:19 PM

Mannatech Q1 Net Income $1.0M, EPS $0.49; Sales Down 8.1%

AI Summary

Mannatech, a global health and wellness company, announced financial results for the first quarter of 2026. The company reported a net income of $1.0 million, or $0.49 per diluted share, a significant improvement from a net loss of $1.5 million in the prior year. However, net sales decreased by $1.6 million to $24.9 million, representing an 8.1% decline on a constant dollar basis, and the customer base also saw a decline.

Key Highlights

  • Net income was $1.0 million, or $0.49 per diluted share, compared to a net loss of $1.5 million, or $(0.80) per diluted share, in Q1 2025.
  • Net sales decreased by $1.6 million to $24.9 million, down 8.1% on a constant dollar basis, compared to Q1 2025.
  • Gross profit as a percentage of net sales increased to 75.7% for Q1 2026, up from 74.3% for the same period in 2025.
  • Loss from operations improved to $0.2 million for Q1 2026, compared to a $0.8 million loss in Q1 2025.
  • Cash and cash equivalents increased 13.4%, or $0.8 million, to $7.0 million as of March 31, 2026.
  • The number of new and continuing independent associate and preferred customer positions decreased to approximately 111,000 from 129,000 in Q1 2025.
  • Americas net sales were $6.7 million (26.9% of total), Asia/Pacific $15.9 million (63.9%), and EMEA $2.3 million (9.2%).